IL24946A - Process for preparing antibodies in cilus pertussis - Google Patents

Process for preparing antibodies in cilus pertussis

Info

Publication number
IL24946A
IL24946A IL2494666A IL2494666A IL24946A IL 24946 A IL24946 A IL 24946A IL 2494666 A IL2494666 A IL 2494666A IL 2494666 A IL2494666 A IL 2494666A IL 24946 A IL24946 A IL 24946A
Authority
IL
Israel
Prior art keywords
pertussis
cell wall
wall material
protective
antigen
Prior art date
Application number
IL2494666A
Other languages
English (en)
Hebrew (he)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL24946A publication Critical patent/IL24946A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL2494666A 1965-01-19 1966-01-10 Process for preparing antibodies in cilus pertussis IL24946A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42669165A 1965-01-19 1965-01-19

Publications (1)

Publication Number Publication Date
IL24946A true IL24946A (en) 1969-05-28

Family

ID=23691819

Family Applications (1)

Application Number Title Priority Date Filing Date
IL2494666A IL24946A (en) 1965-01-19 1966-01-10 Process for preparing antibodies in cilus pertussis

Country Status (11)

Country Link
BE (1) BE675310A (xx)
BR (1) BR6676474D0 (xx)
DE (1) DE1617605C3 (xx)
DK (1) DK115720B (xx)
ES (1) ES322331A1 (xx)
FR (2) FR1475742A (xx)
GB (1) GB1119543A (xx)
IL (1) IL24946A (xx)
NL (1) NL6600703A (xx)
NO (1) NO116869B (xx)
SE (1) SE326797B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
US4338299A (en) * 1980-11-17 1982-07-06 Dso "Pharmachim" Vaccine against pertussis
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
JP2002502311A (ja) * 1997-06-04 2002-01-22 セルラー インプルーブメンツ リミテッド 生物材料の破砕のための方法および装置

Also Published As

Publication number Publication date
BR6676474D0 (pt) 1973-09-11
DK115720B (da) 1969-11-03
FR5550M (xx) 1967-11-20
DE1617605A1 (de) 1971-04-01
SE326797B (xx) 1970-08-03
NL6600703A (xx) 1966-07-20
BE675310A (xx) 1966-07-19
GB1119543A (en) 1968-07-10
NO116869B (xx) 1969-06-02
DE1617605B2 (de) 1974-01-31
FR1475742A (fr) 1967-04-07
DE1617605C3 (de) 1974-08-29
ES322331A1 (es) 1966-11-16

Similar Documents

Publication Publication Date Title
US4197290A (en) Vaccine
Gladstone Immunity to anthrax: protective antigen present in cell-free culture filtrates
Stephens Immune responses of some insects to some bacterial antigens
Jawetz et al. Avirulent strains of Pasteurella pestis
US3395219A (en) Process for production of pertussis antigen
MacLeod et al. Stepwise intratype transformation of pneumococcus from R to S by way of a variant intermediate in capsular polysaccharide production
Tatner et al. Factors influencing the uptake of 14C‐labelled Vibrio anguillarum vaccine in direct immersion experiments with rainbow trout, Salmo gairdneri Richardson
CA1154382A (en) Vaccine and method of making
US4311797A (en) Anucleated live E. coli vaccine
EP0041897B1 (en) Polysaccharide antigen from streptococcus and vaccines
Agius et al. Immunization of rainbow trout, Salmo gairdneri Richardson, against vibriosis: comparison of an extract antigen with whole cell bacterins by oral and intraperitoneal routes
US4203971A (en) Neisseria gonorrhoeae vaccine
Watson et al. Studies on Infection with Bacillus anthracis: III. Chemical and Immunological Properties of the Protective Antigen in Crude Extracts of Skin Lesions of B. anthraci
WO1993021951A1 (en) Method for producing a bacterial vaccine and novel vaccines produced thereby
Kusuda et al. The efficacy of attenuated live bacterin of Pusteurella piscicids against pseudotuberculosis in yellowtail
IL24946A (en) Process for preparing antibodies in cilus pertussis
US4367222A (en) Immune globulin specific to Group B streptococci
Lynn et al. Immunoprotective activity of ribosomes from Haemophilus influenzae
US3465078A (en) Method of recovering antigens from bordetella pertussis cells
US3141824A (en) Pertussis antigen
US4367223A (en) Vaccine against Group B streptococci
US4356263A (en) Method of making a polysaccharide vaccine
US4367221A (en) Immunization against Group B streptococci
Hanson et al. Immunization of mice with irradiated Trypanosoma cruzi grown in cell culture: Relation of numbers of parasites, immunizing injections, and route of immunization to resistance
Youmans et al. Further studies on a labile immunogenic particulate substance isolated from Mycobacterium tuberculosis